MGTA Annual EBITDA
-$78.98 M
-$6.30 M-8.68%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual earnings before interest, taxes, depreciation & amortization is -$78.98 million, with the most recent change of -$6.30 million (-8.68%) on December 31, 2022. During the last 3 years, it has risen by +$2.15 million (+2.65%).MGTA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly EBITDA
-$5.46 M
+$8.25 M+60.19%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly earnings before interest, taxes, depreciation & amortization is -$5.46 million, with the most recent change of +$8.25 million (+60.19%) on June 30, 2023. Over the past year, it has increased by +$12.15 million (+69.00%).MGTA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA TTM EBITDA
-$57.21 M
+$12.15 M+17.52%
30 June 2023
Summary:
As of January 21, 2025, MGTA TTM earnings before interest, taxes, depreciation & amortization is -$57.21 million, with the most recent change of +$12.15 million (+17.52%) on June 30, 2023. Over the past year, it has increased by +$21.04 million (+26.88%).MGTA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.7% | +69.0% | +26.9% |
| 3 y3 years | +2.6% | +72.0% | +33.9% |
| 5 y5 years | -123.4% | +60.6% | +29.5% |
MGTA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +752.7% | +14.2% | +1097.4% |
Magenta Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$5.46 M(-60.2%) | -$57.21 M(-17.5%) |
| Mar 2023 | - | -$13.71 M(-35.5%) | -$69.36 M(-12.2%) |
| Dec 2022 | -$78.98 M(+8.7%) | -$21.27 M(+26.7%) | -$78.98 M(+2.1%) |
| Sept 2022 | - | -$16.78 M(-4.7%) | -$77.32 M(-1.2%) |
| June 2022 | - | -$17.61 M(-24.5%) | -$78.25 M(+0.6%) |
| Mar 2022 | - | -$23.32 M(+19.0%) | -$77.77 M(+7.0%) |
| Dec 2021 | -$72.67 M(-5.3%) | -$19.61 M(+10.7%) | -$72.67 M(+1.4%) |
| Sept 2021 | - | -$17.71 M(+3.4%) | -$71.64 M(-0.2%) |
| June 2021 | - | -$17.13 M(-6.0%) | -$71.81 M(-3.2%) |
| Mar 2021 | - | -$18.22 M(-1.9%) | -$74.20 M(-3.3%) |
| Dec 2020 | -$76.72 M | -$18.57 M(+3.8%) | -$76.72 M(-6.8%) |
| Sept 2020 | - | -$17.89 M(-8.4%) | -$82.31 M(-4.9%) |
| June 2020 | - | -$19.52 M(-5.9%) | -$86.58 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$20.75 M(-14.1%) | -$85.95 M(+5.9%) |
| Dec 2019 | -$81.13 M(+37.3%) | -$24.15 M(+9.0%) | -$81.13 M(+8.8%) |
| Sept 2019 | - | -$22.16 M(+17.3%) | -$74.55 M(+8.2%) |
| June 2019 | - | -$18.89 M(+18.6%) | -$68.88 M(+7.9%) |
| Mar 2019 | - | -$15.93 M(-9.4%) | -$63.86 M(+8.1%) |
| Dec 2018 | -$59.09 M(+67.1%) | -$17.57 M(+6.5%) | -$59.09 M(+19.2%) |
| Sept 2018 | - | -$16.49 M(+19.0%) | -$49.56 M(+24.0%) |
| June 2018 | - | -$13.87 M(+24.2%) | -$39.96 M(-4.2%) |
| Mar 2018 | - | -$11.16 M(+38.8%) | -$41.73 M(+18.1%) |
| Dec 2017 | -$35.35 M(+281.7%) | -$8.04 M(+16.6%) | -$35.35 M(+29.4%) |
| Sept 2017 | - | -$6.90 M(-55.9%) | -$27.31 M(+33.8%) |
| June 2017 | - | -$15.63 M(+227.2%) | -$20.41 M(+327.2%) |
| Mar 2017 | - | -$4.78 M | -$4.78 M |
| Dec 2016 | -$9.26 M | - | - |
FAQ
- What is Magenta Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Magenta Therapeutics?
- What is Magenta Therapeutics annual EBITDA year-on-year change?
- What is Magenta Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly EBITDA year-on-year change?
- What is Magenta Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Magenta Therapeutics?
- What is Magenta Therapeutics TTM EBITDA year-on-year change?
What is Magenta Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MGTA is -$78.98 M
What is the all time high annual EBITDA for Magenta Therapeutics?
Magenta Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$9.26 M
What is Magenta Therapeutics annual EBITDA year-on-year change?
Over the past year, MGTA annual earnings before interest, taxes, depreciation & amortization has changed by -$6.30 M (-8.68%)
What is Magenta Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MGTA is -$5.46 M
What is the all time high quarterly EBITDA for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$4.78 M
What is Magenta Therapeutics quarterly EBITDA year-on-year change?
Over the past year, MGTA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$12.15 M (+69.00%)
What is Magenta Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MGTA is -$57.21 M
What is the all time high TTM EBITDA for Magenta Therapeutics?
Magenta Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$4.78 M
What is Magenta Therapeutics TTM EBITDA year-on-year change?
Over the past year, MGTA TTM earnings before interest, taxes, depreciation & amortization has changed by +$21.04 M (+26.88%)